Trial Profile
Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacodynamics; Therapeutic Use
- 26 Apr 2013 New trial record